Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

12

Revenue 2017

Bayer

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Bayer's 2013 sales performance.

Bayer

Immuno-oncology, personalised medicine continues to drive pharma sector

Immuno-oncology, personalised medicine continues to drive pharma sector

A recent example of this issue is Bayer’s tumour-agnostic drug Vitrakvi (larotrectinib), which targets all solid tumours that display a NTRK gene fusion regardless of cancer type, but was ... discussion with Bayer for access to the drug.

NICE leaves the ‘the NHS door’ open despite rejecting Bayer’s Vitrakvi

NICE leaves the ‘the NHS door’ open despite rejecting Bayer’s Vitrakvi The UK’s National Institute for Health and Care Excellence (NICE) says it cannot recommend Bayer’s tumour-agnostic drug Vitrakvi at its current price, but remain ‘open’ for further discussion. . ... Although Bayer has had a head start in the EU

Newly-listed BioNTech buys Neon to boost cell therapy assets

Newly-listed BioNTech buys Neon to boost cell therapy assets German biotech has agreed to pay $67m in the deal

HTA guidance from NICE, the SMC and the AWMSG

Here we present a feed of upcoming health technology assessment (HTA) decisions, covering appraisals by the National Institute of Health and Care Excellence (NICE), the Scottish Medicines Consortium (SMC) and the All Wales Medicines Strategy Group

Bayer bulks up in women’s health again with non-hormonal contraceptive deal

Bayer bulks up in women’s health again with non-hormonal contraceptive deal If approved candidate would become a first-in-category therapy. Bayer’s partnering spree shows no sign of letting up, as it agrees a licensing deal with Daré Bioscience for a ... We believe Bayer is best positioned to maximise the market opportunity

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Frontera Group

Welcome to Frontera Group, where our agencies immerse you in the world of the patient...

Latest intelligence

OPEN Health expands offering with the launch of a new Learning & Development specialist team
Enhanced expertise to deliver impactful internal training programmes for healthcare clients...
Figure 1 Clarivate
The changing nature of approvals – what does the future hold?
The 2019 CMR International Pharmaceutical R&D Factbook...
Spotlight interview: 15 minutes on healthcare communications in gene therapy
Gavin Jones, Director of Rare Disease, OPEN Health takes 15 minutes to answer some key questions on healthcare communications in gene therapy...

Infographics